Sakar Healthcare Q1 Profit Doubles to ₹10 Crore on Export Growth
NiveshIQ
NSE: ASTERDM · Healthcare
Aster DM Healthcare Ltd.
₹818.35▲ ₹4.85 (+0.60%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on ASTERDM. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Aster DM Healthcare Ltd.
Aster DM Quality Care Limited is an integrated healthcare provider in India, operating through four healthcare brands: Aster DM, CARE Hospitals, Evercare, and KIMSHEALTH. The company offers comprehensive healthcare services across key areas, including oncology, cardiac sciences, and mother and childcare. Aster DM Quality Care Limited operates retail pharmacies and optical outlets, expanding its reach in the healthcare sector. Recently, the company announced a ₹1,315 crore expansion in Karnataka, reaffirming its commitment to the region. This significant investment is expected to drive growth and improve the company's market position. With a strong presence in the Indian healthcare market, Aster DM Quality Care Limited is well-positioned for future growth. The company's focus on quality car
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹3,699 Cr -7.50% | ₹4,138 Cr +11.90% | ₹4,643 Cr +12.20% |
| EBITDA Margin | 15.30% | 18.03% | 19.57% |
| Net Profit | ₹212.00 Cr -38.00% | ₹5,408 Cr +2450.90% | ₹427.58 Cr -92.10% |
| EPS | ₹2.59 | ₹107.66 | ₹7.50 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Aster DM Healthcare to rename as Aster DM Quality Care Limited
Aster DM Healthcare: కర్ణాటకలో భారీ విస్తరణకు సిద్ధం.. ₹1,315 కోట్ల పెట్టుబడి!
🔒
+ 3 more stories about Aster DM Healthcare Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹1, 182 Cr, PAT ₹154 Cr, EPS ₹2.72, EBITDA margin 22.7%. Growth context: revenue YoY +18.2%, PAT YoY +78.6%, revenue QoQ -0.3%, PAT QoQ +160.3%. Street verdict: strong beat, revenue surprise +4.5%, PAT surprise +85.7%.
Recent corporate activity highlights new capacity addition and capex deployment and geographic expansion and internation...
FY26 (last completed FY): revenue ₹4, 643 Cr, PAT ₹428 Cr, EBITDA margin 19.6%, EPS ₹7.50. Year-on-year: revenue YoY +12...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for ASTERDM
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track ASTERDM alongside your other holdings
Unlock full ASTERDM research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Aster DM Healthcare Ltd.?
NiveshIQ detects active intelligence signals for Aster DM Healthcare Ltd. (ASTERDM) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Aster DM Healthcare Ltd.?
Aster DM Healthcare Ltd. operates in the Healthcare sector with a market capitalisation of ₹3,835,669.1L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.